WCN26-4701 CLINICAL PROFILE AND TREATMENT OUTCOMES OF THERAPEUTIC APHERESIS FOR RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS AFTER KIDNEY TRANSPLANTATION

Read full text Summarise with VIRAT
Authors: Chimezie Godswill Okwuonu, Muzamil Olamide Hassan, Olalekan Ojo, Rasheed Abiodun Balogun
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Recurrence of focal segmental glomerulosclerosis (FSGS) following kidney transplantation remains a significant cause of allograft loss. Much remains unknown about the efficacy of apheresis treatments and the factors that determine favorable treatment outcomes.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105484–105484
Publication date
25 March 2026
Language
EN